Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma

Am J Hematol. 2024 Nov;99(11):2222-2224. doi: 10.1002/ajh.27452. Epub 2024 Aug 7.

Affiliations

¹ Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
² Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
³ Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

PMID: 39109821
DOI: 10.1002/ajh.27452

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Autografts
Female
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Male
Middle Aged
Multiple Myeloma* / therapy
Neoplasms, Second Primary* / etiology
Transplantation, Autologous*